DNA damage and its repair in lymphocytes and thyroid nodule cells during radioiodine therapy in patients with hyperthyroidism

被引:7
|
作者
Grzesiuk, W.
Nieminuszczy, J.
Kruszewski, M.
Iwanienko, T.
Plazinska, M.
Bogdanska, M.
Bar-Andziak, E.
Krolicki, L.
Grzesiuk, E.
机构
[1] PAS, Inst Biochem & Biophys, Dept Biol Mol, PL-02106 Warsaw, Poland
[2] Univ Warsaw, Sch Med, Dept Internal Med & Endocrinol, Warsaw, Poland
[3] Inst Nucl Chem & Technol, Dept Radiobiol & Hlth Protect, PL-03195 Warsaw, Poland
[4] Univ Warsaw, Sch Med, Dept Nucl Med, Warsaw, Poland
[5] Univ Warsaw, Sch Med, Dept Pathol, Warsaw, Poland
关键词
D O I
10.1677/jme.1.02174
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Radioiodine treatment of hyperthyroid patients with autonomous thyroid nodule leads to cellular DNA damage not only in thyrocytes but also in peripheral blood lymphocytes. The purpose of this study was to evaluate DNA breakage and base damage in thyrocytes and lymphocytes in patients treated with 131-1. In all the patients thyroid scintiscan was performed using 131-1. Damage to DNA was estimated by comet assay. Samples were taken before radioiodine treatment, and 12 and 54 days afterwards. Our results indicate high diversity in the level of DNA damage among the individual patients. However, in all cases, after 54 days the level of DNA damage in lymphocytes was similar or even lower than that in the controls. In contrast, in hot nodule the DNA damage persisted until the 54th day after 131-1 application. Differences in the type of DNA damage between thyrocytes and lymphocytes were also observed. In lymphocytes there was more base damage, whereas in thyrocytes single strand breaks prevailed. This may indicate different mechanisms of DNA damage induction and/or DNA repair.
引用
收藏
页码:527 / 532
页数:6
相关论文
共 50 条
  • [1] DNA Damage in Peripheral Blood Lymphocytes of Thyroid Cancer Patients After Radioiodine Therapy
    Eberlein, Uta
    Scherthan, Harry
    Bluemel, Christina
    Peper, Michel
    Lapa, Constantin
    Buck, Andreas Konrad
    Port, Matthias
    Lassmann, Michael
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (02) : 173 - 179
  • [2] Different DNA Damage Repair Rates in Blood Lymphocytes after Peptide Receptor Radionuclide Therapy and Radioiodine Therapy of Thyroid Cancer
    Eberlein, U.
    Nowak, C.
    Lapa, C.
    Bluemel, C.
    Peper, M.
    Werner, R. A.
    Buck, A. K.
    Scherthan, H.
    Lassmann, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S114 - S114
  • [3] A Model to Describe the DNA Damage Response in Blood Cells During Radioiodine Therapy
    Schumann, S.
    Scherthan, H.
    Schoof, S.
    Hartrampf, P.
    Buck, A. K.
    Port, M.
    Lassmann, M.
    Eberlein, U.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S362 - S362
  • [4] Radioiodine therapy of the autonomous thyroid nodule in patients with or without visible extranodular activity
    Als, C
    Rosler, H
    Kinser, JA
    JOURNAL OF NUCLEAR MEDICINE, 1996, 37 (02) : 401 - 402
  • [5] Dosimetry study in patients with autonomous thyroid nodule who are candidates for radioiodine therapy
    Reschini, E
    Matheoud, R
    Canzi, C
    Castellani, M
    Galelli, M
    Ferrari, C
    Paracchi, A
    Gerundini, P
    JOURNAL OF NUCLEAR MEDICINE, 1999, 40 (11) : 1928 - 1934
  • [6] Effect of radioiodine therapy on thyroid nodule size and function in patients with toxic adenomas
    Erdogan, MF
    Küçük, NÖ
    Anil, C
    Aras, S
    Özer, D
    Aras, G
    Kamel, N
    NUCLEAR MEDICINE COMMUNICATIONS, 2004, 25 (11) : 1083 - 1087
  • [7] Are There Differences in DNA Damage Induction and Repair Before and After Radioiodine Therapy?
    Schumann, S.
    Scherthan, H.
    Schoof, S.
    Hartrampf, P. E.
    Buck, A. K.
    Port, M.
    Lassmann, M.
    Eberlein, U.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S146 - S146
  • [8] RADIOIODINE THERAPY OF THE AUTONOMOUS THYROID-NODULE IN PATIENTS WITH OR WITHOUT VISIBLE EXTRANODULAR ACTIVITY
    CLERC, J
    DAGOUSSET, F
    IZEMBART, M
    JAIS, JP
    HESHMATI, HM
    ALCAIS, A
    CHEVALIER, A
    LEGER, AF
    BARRITAULT, L
    JOURNAL OF NUCLEAR MEDICINE, 1995, 36 (02) : 217 - 223
  • [9] Radioiodine therapy of the autonomous thyroid nodule in patients with or without visible extranodular activity - Reply
    Clere, J
    Dagousset, F
    Izembart, M
    Jais, JP
    Alcais, A
    Chevalier, A
    Leger, A
    Barritault, L
    JOURNAL OF NUCLEAR MEDICINE, 1996, 37 (02) : 402 - 403
  • [10] Micronuclei frequency in peripheral blood lymphocytes of thyroid cancer patients after radioiodine therapy and its relationship with metastasis
    Joseph, Lebana J.
    Bhartiya, Uma S.
    Raut, Yogita S.
    Kand, Purushottam
    Hawaidar, Rohini W.
    Nair, Narendra
    MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS, 2009, 675 (1-2) : 35 - 40